BCPC Quote, Financials, Valuation and Earnings

5E Advanced Materials has a net margin of 13.99% compared to Balchem's net margin of --. Balchem's return on equity of 11.53% beat 5E Advanced Materials's return on equity of --.

Balchem has a consensus price target of $199.33, signalling upside risk potential of 19.72%. On the other hand 5E Advanced Materials has an analysts' consensus of $29.00 which suggests that it could grow by 820.63%. Given that 5E Advanced Materials has higher upside potential than Balchem, analysts believe 5E Advanced Materials is more attractive than Balchem.

Balchem has a beta of 0.627, which suggesting that the stock is 37.287% less volatile than S&P 500. In comparison 5E Advanced Materials has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. 5E Advanced Materials offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 19.91% of its earnings as a dividend. 5E Advanced Materials pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $240M, which are larger than 5E Advanced Materials quarterly revenues of --. Balchem's net income of $33.6M is higher than 5E Advanced Materials's net income of -$14.3M. Notably, Balchem's price-to-earnings ratio is 42.37x while 5E Advanced Materials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.71x versus -- for 5E Advanced Materials. Usually stocks with elevated PS ratios are considered overvalued.

Innospec has a net margin of 13.99% compared to Balchem's net margin of -15.08%. Balchem's return on equity of 11.53% beat Innospec's return on equity of 2.97%.

Balchem has a consensus price target of $199.33, signalling upside risk potential of 19.72%. On the other hand Innospec has an analysts' consensus of $131.50 which suggests that it could grow by 35.85%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

Balchem has a beta of 0.627, which suggesting that the stock is 37.287% less volatile than S&P 500. In comparison Innospec has a beta of 1.076, suggesting its more volatile than the S&P 500 by 7.631%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. Innospec offers a yield of 1.6% to investors and pays a quarterly dividend of $0.79 per share. Balchem pays 19.91% of its earnings as a dividend. Innospec pays out 108.99% of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

Balchem quarterly revenues are $240M, which are smaller than Innospec quarterly revenues of $466.8M. Balchem's net income of $33.6M is higher than Innospec's net income of -$70.4M. Notably, Balchem's price-to-earnings ratio is 42.37x while Innospec's PE ratio is 69.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.71x versus 1.32x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

The Mosaic has a net margin of 13.99% compared to Balchem's net margin of 6%. Balchem's return on equity of 11.53% beat The Mosaic's return on equity of 1.46%.

Balchem has a consensus price target of $199.33, signalling upside risk potential of 19.72%. On the other hand The Mosaic has an analysts' consensus of $31.99 which suggests that it could grow by 27.64%. Given that The Mosaic has higher upside potential than Balchem, analysts believe The Mosaic is more attractive than Balchem.

Balchem has a beta of 0.627, which suggesting that the stock is 37.287% less volatile than S&P 500. In comparison The Mosaic has a beta of 1.345, suggesting its more volatile than the S&P 500 by 34.465%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. The Mosaic offers a yield of 3.39% to investors and pays a quarterly dividend of $0.22 per share. Balchem pays 19.91% of its earnings as a dividend. The Mosaic pays out 154.77% of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but The Mosaic's is not.

Balchem quarterly revenues are $240M, which are smaller than The Mosaic quarterly revenues of $2.8B. Balchem's net income of $33.6M is lower than The Mosaic's net income of $169M. Notably, Balchem's price-to-earnings ratio is 42.37x while The Mosaic's PE ratio is 45.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.71x versus 0.72x for The Mosaic. Usually stocks with elevated PS ratios are considered overvalued.

WD-40 has a net margin of 13.99% compared to Balchem's net margin of 12.33%. Balchem's return on equity of 11.53% beat WD-40's return on equity of 31.98%.

Balchem has a consensus price target of $199.33, signalling upside risk potential of 19.72%. On the other hand WD-40 has an analysts' consensus of $296.00 which suggests that it could grow by 24.65%. Given that WD-40 has higher upside potential than Balchem, analysts believe WD-40 is more attractive than Balchem.

Balchem has a beta of 0.627, which suggesting that the stock is 37.287% less volatile than S&P 500. In comparison WD-40 has a beta of -0.102, suggesting its less volatile than the S&P 500 by 110.204%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. WD-40 offers a yield of 1.51% to investors and pays a quarterly dividend of $0.94 per share. Balchem pays 19.91% of its earnings as a dividend. WD-40 pays out 67.78% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $240M, which are larger than WD-40 quarterly revenues of $153.5M. Balchem's net income of $33.6M is higher than WD-40's net income of $18.9M. Notably, Balchem's price-to-earnings ratio is 42.37x while WD-40's PE ratio is 45.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.71x versus 5.34x for WD-40. Usually stocks with elevated PS ratios are considered overvalued.